13
Participants
Start Date
January 31, 2006
Primary Completion Date
January 31, 2009
Study Completion Date
January 31, 2009
ANTI-IGE THERAPY (XOLAIR)
Xolair dosing is based on body weight and baseline serum total IgE concentration(0.016 x kg body weight x IgE levels), with a maximum dose per 4 weeks of 750mg.Depending on their weight and IgE levels, patients get their Xolair shots every 2 or every 4 weeks.
Collaborators (2)
Novartis
INDUSTRY
Genentech, Inc.
INDUSTRY
Children's Hospital of The King's Daughters
OTHER